Batlevi, Connie Lee
Matsuki, Eri
Brentjens, Renier J.
Younes, Anas
Article History
First Online: 3 November 2015
Competing interests
: R.J.B. declares he is the Scientific Cofounder of JUNO Therapeutics and receives research support from the National Institutes of Health (grants CA095152, CA138738, CA059350, CA008748), Juno Therapeutics, the William Lawrence Blanche Hughes Foundation, The Emerald Foundation, the Damon Runyon Clinical Investigator Award, the Annual Terry Fox Run for Cancer Research, Kate's Team, the Mr William H. Goodwin and Mrs Alice Goodwin and the Commonwealth Cancer Foundation for Research, the Experimental Therapeutics Center of Memorial Sloan–Kettering Cancer Center, and the Geoffrey Beene Cancer Foundation. A.Y. receives honouraria from Bayer, BMS, Celgene, Incyte, Janssen R&D, Sanofi, Seattle Genetics, and Takeda Millenium, and research support from the John and Barbara Vogelstein Foundation. C.B. is supported by the Mortimer J. Lacher Foundation. E.M. declares no competing interests.
Free to read: This content has been made available to all.